Home > Drug Search >
  • company_query: Accera
  •   > 
Drug Filter
Category:
chemistry (23) biology (5)
Status:
Approved (4) Phase Ⅲ (3) Phase Ⅱ (11) Phase Ⅰ (10)
Clinical Stage:
Pending (4) Active (10) Discontinued (10)
Bio-Type:
Vaccine (1) Whole antibody (4)
Indication:
Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (2) Asthma (1) Atopic dermatitis (2) Breast cancer (1) Castration-resistant prostate cancer (CRPC) (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Crohn's disease (2) Diabetic nephropathy (1) Follicular lymphoma (1) Gastric cancer (2) Hepatocellular carcinoma (HCC) (1) Influenza virus infection (1) Insomnia (1) Leiomyoma (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (2) Pertussis (1) Prostate cancer (1) Psoriasis (2) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (4) Sleep disorder (1) Solid tumours (8) Ulcerative colitis (2) Head and neck cancer (1) Ankylosing Spondylitis (AS) (1) Colon cancer (1) Microscopic polyangiitis (1) Granulomatosis with polyangiitis (1) Cholangiocarcinoma (1) Stroke (1) Bipolar disorder (1) Pediatric Crohn’s disease (1) Hematological cancer (1) Autoimmune diseases (1) Plaque psoriasis (2) Diffuse large B cell lymphoma (1) Left ventricular systolic dysfunction (LVSD) (1) Proteus Syndrome (PS) (1) Renal failure (1)
Aprv. Year:
2013 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top